Prolonged progression-free survival in patients with chronic lymphocytic leukemia receiving granulocyte colony-stimulating factor during treatment with fludarabine, cyclophosphamide, and rituximab.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples